| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.073 | 0.6 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.072 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.15 | 0.6 |